Literature DB >> 28548903

Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks.

Yang Wang1,2, Kazuki Takeishi2,3, Zhao Li1, Eduardo Cervantes-Alvarez2,4, Alexandra Collin de l'Hortet2, Jorge Guzman-Lepe2, Xiao Cui1, Jiye Zhu1.   

Abstract

Organ-like microenviroment and 3-dimensional (3D) cell culture conformations have been suggested as promising approaches to mimic in a micro-scale a whole organ cellular functions and interactions present in vivo. We have used this approach to examine biologic features of hepatocellular carcinoma (HCC) cells. In this study, we demonstrate that hepatocellular carcinoma (HCC) cells, fibroblasts, endothelial cells and extracellular matrix can generate organoid-like spheroids that enhanced numerous features of human HCC observed in vivo. We show that the addition of non-parenchymal cells such as fibroblast and endothelial cells is required for spheroid formation as well as the maintenance of the tissue-like structure. Furthermore, HCC cells cultured as spheroids with non-parenchymal cells express more neo-angiogenesis-related markers (VEGFR2, VEGF, HIF-α), tumor-related inflammatory factors (CXCR4, CXCL12, TNF-α) and molecules-related to induced epithelial-mesenchymal transition (TGFβ, Vimentin, MMP9) compared with organoids containing only HCC cells. These results demonstrate the importance of non-parenchymal cells in the cellular composition of HCC organoids. The novelty of the multicellular-based organotypic culture system strongly supports the integration of this approach in a high throughput approach to identified patient-specific HCC malignancy and accurate anti-tumor therapy screening after surgery.

Entities:  

Keywords:  endothelial cell; fibroblast; hepatocellular carcinoma; organoid; tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28548903      PMCID: PMC5654820          DOI: 10.1080/15476278.2017.1322243

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  39 in total

1.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Engineering of human hepatic tissue with functional vascular networks.

Authors:  Takanori Takebe; Naoto Koike; Keisuke Sekine; Ryoji Fujiwara; Takeru Amiya; Yun-Wen Zheng; Hideki Taniguchi
Journal:  Organogenesis       Date:  2014-01-22       Impact factor: 2.500

3.  Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor.

Authors:  G K Michalopoulos; W C Bowen; V F Zajac; D Beer-Stolz; S Watkins; V Kostrubsky; S C Strom
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Engineering of an hepatic organoid to develop liver assist devices.

Authors:  Alejandro Soto-Gutierrez; Nalú Navarro-Alvarez; Hiroshi Yagi; Yakoov Nahmias; Martin L Yarmush; Naoya Kobayashi
Journal:  Cell Transplant       Date:  2010-06-23       Impact factor: 4.064

5.  Effects of medium composition on the morphology and function of rat hepatocytes cultured as spheroids and monolayers.

Authors:  G A Hamilton; C Westmorel; A E George
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.

Authors:  Jiao Liu; Sheng Chen; Wei Wang; Bei-Fang Ning; Fei Chen; Weifeng Shen; Jin Ding; Wansheng Chen; Wei-Fen Xie; Xin Zhang
Journal:  Cancer Lett       Date:  2016-05-20       Impact factor: 8.679

8.  Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.

Authors:  Kyle W McCracken; Emily M Catá; Calyn M Crawford; Katie L Sinagoga; Michael Schumacher; Briana E Rockich; Yu-Hwai Tsai; Christopher N Mayhew; Jason R Spence; Yana Zavros; James M Wells
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

Review 9.  Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth.

Authors:  Kazuyoshi Shiga; Masayasu Hara; Takaya Nagasaki; Takafumi Sato; Hiroki Takahashi; Hiromitsu Takeyama
Journal:  Cancers (Basel)       Date:  2015-12-11       Impact factor: 6.639

10.  Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.

Authors:  Chunyu Zhang; Li Fu; Jianhua Fu; Liang Hu; Hong Yang; Tie-Hua Rong; Yan Li; Haibo Liu; Song-Bin Fu; Yi-Xin Zeng; Xin-Yuan Guan
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

View more
  11 in total

Review 1.  Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models.

Authors:  Sang Woo Lee; Da Jung Jung; Gi Seok Jeong
Journal:  Tissue Eng Regen Med       Date:  2020-03-23       Impact factor: 4.169

Review 2.  Immune response triggered by the ablation of hepatocellular carcinoma with nanosecond pulsed electric field.

Authors:  Jianpeng Liu; Xinhua Chen; Shusen Zheng
Journal:  Front Med       Date:  2020-11-13       Impact factor: 4.592

Review 3.  3D modeling in cancer studies.

Authors:  Oula El Atat; Zahra Farzaneh; Mahsa Pourhamzeh; Fatima Taki; Ralph Abi-Habib; Massoud Vosough; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2021-11-10       Impact factor: 4.174

4.  Cyclooxygenase-2 expressed hepatocellular carcinoma induces cytotoxic T lymphocytes exhaustion through M2 macrophage polarization.

Authors:  Xiaodong Xun; Changkun Zhang; Siqi Wang; Shihua Hu; Xiao Xiang; Qian Cheng; Zhao Li; Yang Wang; Jiye Zhu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 5.  Organoids for the Study of Liver Cancer.

Authors:  Haichuan Wang; Diego F Calvisi; Xin Chen
Journal:  Semin Liver Dis       Date:  2021-02-09       Impact factor: 6.115

Review 6.  3D tumor angiogenesis models: recent advances and challenges.

Authors:  Sharath M Bhat; Vaishnavi A Badiger; Sampara Vasishta; Juhi Chakraborty; Seetharam Prasad; Sourabh Ghosh; Manjunath B Joshi
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-06       Impact factor: 4.553

Review 7.  Tumor organoids: applications in cancer modeling and potentials in precision medicine.

Authors:  Hanxiao Xu; Dechao Jiao; Aiguo Liu; Kongming Wu
Journal:  J Hematol Oncol       Date:  2022-05-12       Impact factor: 23.168

Review 8.  Organoid models of gastrointestinal cancers in basic and translational research.

Authors:  Harry Cheuk Hay Lau; Onno Kranenburg; Haipeng Xiao; Jun Yu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-25       Impact factor: 46.802

Review 9.  Liver Illness and Psoriatic Patients.

Authors:  Marco Fiore; Sebastiano Leone; Alberto Enrico Maraolo; Emilio Berti; Giovanni Damiani
Journal:  Biomed Res Int       Date:  2018-02-06       Impact factor: 3.411

Review 10.  Models for Understanding Resistance to Chemotherapy in Liver Cancer.

Authors:  Jose J G Marin; Elisa Herraez; Elisa Lozano; Rocio I R Macias; Oscar Briz
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.